Phillip Ramsey

UltraDns SendInBlue Outlook Microsoft Office 365 Drupal Remote

biotechnology genome editing gene therapy mps ii mps i hemophilia a hemophilia b beta thalassemia fabry cell therapy tauopathies immunology biotechnology: biological products (no diagnostic substances) health care biotechnology research genomic medicine zinc finger technology aav capsid neurological diseases fabry disease clinical trials car-t therapy drug delivery patient safety genome engineering ex vivo therapy in vivo therapy modular integrase patient stories pipeline development approved therapies substitute treatments chronic neuropathic pain collaborations biotech partnerships precision medicine therapeutic applications sickle cell disease autoimmunity renal transplantation patient-focused bioethics fda clearance research & development phase 1 trial phase 2 trial clinical programs efficacy & safety brca1 gene therapy chronic pain management cns diseases viral vectors epigenetic regulators innovative therapies gene editing publications patient resources medical advancements transformative therapies life sciences rare diseases disease modification fast track designation hemophilia huntington's disease gene regulation innovative treatments severe diseases patient-centric partnerships pharmaceutical collaborations transformative medicines symptom management healthcare solutions patient outcomes advanced science market growth financial health employee culture strategic alliances capsid engineering blood-brain barrier neurodevelopmental disorders genetic disorders health wellness & fitness hospital & health care